Fierce Pharma August 26, 2024
Breaking the Bottleneck: Streamlining Prior Authorizations and Unlocking Patient Access to Specialty Medications
When Marie D’Orsaneo’s rheumatoid arthritis worsened, her doctor prescribed Rituxan, a pricey injectable medication. But her health plan’s approval process dragged on, turning days into weeks. As she waited, her condition deteriorated, forcing her to quit her job, move in with relatives, and seek inpatient care.
Featured in an NBC News broadcast on the high cost of specialty medications in January 20131, D’Orsaneo’s ordeal was far from unique. The situation for patients has gotten progressively worse in the years since.
With their high cost and need for special handling and administration, specialty drugs often require a prior authorization (PA). In fact, 71% of infusion therapies prescribed for...
Today's Sponsors
Today's Sponsor